- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.12. | Biosecure Act heads to Trump's desk with defense spending bill after Senate vote | ||
| 17.12. | 'Our work is never over': How Lilly's 2026 Olympics team-ups align with its own mission | ||
| 17.12. | Intercept, on heels of Ocaliva withdrawal, restructures with 146 layoffs | ||
| 17.12. | With pivotal trial underway, Ionis ramps up Angelman syndrome awareness with Lifetime TV segment | ||
| 17.12. | Alnylam lays out $250M to equip flagship facility with cutting-edge siRNA production tech | ||
| 17.12. | Hansa falls short in bid to push EU-approved kidney transplant drug into new autoimmune indication | ||
| 17.12. | Keytruda, Padcev keep winning streak with another patient survival benefit in bladder cancer | ||
| 16.12. | Ramaswamy-backed Ambros Therapeutics launches with $125M to develop pain drug | ||
| 16.12. | Fosun Pharma signs up to take on China's Green Valley, revive controversial Alzheimer's med | ||
| 16.12. | Avalere taps longtime Senate staffer to head up healthcare policy team amid regulatory turbulence | ||
| 16.12. | Pfizer shares drop 5% with 2026 revenue projection and long-range outlook | ||
| 16.12. | Novo gets FDA warning letter at troubled Indiana site formerly owned by Catalent | ||
| 16.12. | Gilead's single-tablet HIV combo of bictegravir, lenacapavir passes another late-stage test on way to filings | ||
| 15.12. | AstraZeneca, Daiichi score with FDA nod for Enhertu combo in 1st-line breast cancer | ||
| 15.12. | Novo's oral semaglutide edges out CagriSema, Lilly's orforglipron as PCPs' most-anticipated obesity med | ||
| 15.12. | FDA 'proactively' awards J&J a national priority review voucher for multiple myeloma drug combo | ||
| 15.12. | J&J positions its PARP combo Akeega in new prostate cancer subset with 2nd FDA nod | ||
| 15.12. | Many consumers don't like TV drug ads' frequency, 'misleading' visuals: SiriusXM study | ||
| 15.12. | Cincinnati's LIB scores FDA approval for third-generation PCSK9 drug Lerochol | ||
| 15.12. | Argenx permanently grounds studies of high-flying Vyvgart in thyroid eye disease | ||
| 15.12. | Milestone wins first-ever FDA approval with green light for heart arrhythmia nasal spray | ||
| 12.12. | FDA endorses 2nd new gonorrhea treatment, clearing way for Innoviva's Nuzolvence | ||
| 12.12. | GSK's long-acting asthma med scores in suite of CHMP drug endorsements | ||
| 12.12. | New CDC report backs COVID vaccine effectiveness in children as vaccine safety probe heats up at FDA | ||
| 12.12. | NanoVibronix feeds into new focus on ENvue enteral system with rebrand |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .